Odisolane, a Novel Oxolane Derivative, and Antiangiogenic Constituents from the Fruits of Mulberry (Morus alba L.)

详细信息    查看全文

• 作者：Seoung Rak Lee ; Jun Yeon Park ; Jae Sik Yu ; Sung Ok Lee ; Ja-Young Ryu ; Sang-Zin Choi ; Ki Sung Kang ; Noriko Yamabe ; Ki Hyun Kim
• 刊名：Journal of Agricultural and Food Chemistry
• 出版年：2016
• 出版时间：May 18, 2016
• 年：2016
• 卷：64
• 期：19
• 页码：3804-3809
• 全文大小：378K
• 年卷期：0
• ISSN：1520-5118

文摘

Mulberry, the fruit of Morus alba L., is known as an edible fruit and commonly used in Chinese medicines as a warming agent and as a sedative, tonic, laxative, odontalgic, expectorant, anthelmintic, and emetic. Systemic investigation of the chemical constituents of M. alba fruits led to the identification of a novel oxolane derivative, (R*)-2-((2S*,3R*)-tetrahydro-2-hydroxy-2-methylfuran-3-yl)propanoic acid (1), namely, odisolane, along with five known heterocyclic compounds (2–6). The structure of the new compound was elucidated on the basis of HR-MS, 1D and 2D NMR (¹H–¹H COSY, HSQC, HMBC, and NOESY) data analysis. Compound 1 has a novel skeleton that consists of 8 carbon units with an oxolane ring, which until now has never been identified in natural products. The isolated compounds were subjected to several activity tests to verify their biological function. Among them, compounds 1, 3, and 5 significantly inhibited cord formation in HUVECs. The action mechanism of compound 3, which had the strongest antiangiogenic activity, was mediated by decreasing VEGF, p-Akt, and p-ERK protein expression. These results suggest that compounds isolated from M. alba fruits might be beneficial in antiangiogenesis therapy for cancer treatment.